Peter J. Lansberg MD, PhD

Dr. Peter J. Lansberg is a lipidologist and senior staff member at the Department of Vascular Medicine, Academic Medical Center in Amsterdam, the Netherlands.

Dr. Lansberg obtained his Bachelor, Master and Doctor of Medicine degrees from University of Amsterdam (UvA). He returned to Academic Medical Center (AMC) where he worked on his doctoral thesis “The Molecular Basis and Treatment of Familial Hypercholesterolemia (FH)” at the department of vascular Medicine under the supervision of prof. John Kastelein and prof. Jan Wouter ten Cate.

He established and supervised the Amsterdam Lipid Clinic in the Slotervaart medical center in Amsterdam and during the 1990ies he co-­‐founded, in collaboration with Prof. Kastelein, the Dutch Lipid Clinic Network, a national alliance of Dutch academic and general hospitals. For this network he conceived and promoted the Dutch Lipid Clinic Diagnostic Criteria for FH.

Parallel to the national activities he was active in the international ‘Make Early Diagnosis to Prevent Early Death’ (MedPed) program, initiated by the late Dr. Roger Williams. His focus in both organizations was on developing comprehensive educational programs to improve the clinical management of Familial Hypercholesterolemia patients as well setting up the first electronic health record for the registration of patients with lipid abnormalities. During this period he was involved in a large number of clinical trials focusing on lipid management and genetic research at the department of vascular medicine at the AMC.

Dr. Lansberg is the founder and former director of the successful Dutch National FH Cascade Screening program conducted by the “Stichting Opsporing Erfelijke Hypercholesterolemie” (StOEH). Based on this experience he supported similar initiatives in Europe, Middle East, Southeast Asia, Canada, Australia and New Zealand and shared his experience and expertise, building and managing the Dutch screening program.